معرفی
Joshua Garfield is a Research Fellow at Monash University specializing in addiction psychology, cognitive psychology, and psychopharmacology. His work focuses on developing and evaluating behavioral interventions for substance use disorders, particularly through cognitive bias modification techniques and telehealth applications. He has led or contributed to multiple clinical trials involving alcohol, methamphetamine, and tobacco addiction treatments.
Education: PhD in Psychology from the University of New South Wales (2008), BSc (Honors) in Psychology (2002).
Research Interests: Garfield's studies explore the neurocognitive mechanisms underlying addictive behaviors, digital health solutions for addiction management, and the application of behavioral therapies in clinical settings. His projects often involve collaborations across disciplines and institutions to address real-world treatment challenges.
Key Projects: Includes the AAT-APP Trial (2023-2026), investigating smartphone-based interventions for alcohol use disorders, and a pilot trial of Modify, a smoking cessation app. He has also conducted pivotal work on telehealth effectiveness during the pandemic and nicotine-based treatments for smoking cessation.
Grant Activities: Chief Investigator (CI) on six major research grants totaling over AUD 5 million. Projects span addiction treatment innovations, harm reduction strategies, and translational research bridging lab findings to clinical practice.
Labs/Teams: Collaborates with multidisciplinary teams including Monash Addiction Research Group and National Centre for Clinical Research on Emerging Drugs. Active in peer review for journals like Addiction, Drug and Alcohol Review, and Addictive Behaviors Reports.
